Parkinson's Disease

Abbott and NIH Join Forces to Advance Neuroscience Research
Abbott and NIH Join Forces to Advance Neuroscience Research
Medical Devices and Diagnostics Industry
Abbott Labs
NIH
devices
chronic pain
R&D
Parkinson's Disease
Flag link:
Tencent Starts Collecting Medical Data On U.K. Patients In Parkinson's Trial
Tencent Starts Collecting Medical Data On U.K. Patients In Parkinson's Trial
Forbes
Tencent
clinical trials
Parkinson's Disease
Medopad
artificial intelligence
Flag link:
Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms
Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms
BioSpace
Neurocrine Biosciences
clinical trials
opicapone
Parkinson's Disease
Flag link:
Inflazome grabs Fox Foundation funding for Parkinson’s R&D
Inflazome grabs Fox Foundation funding for Parkinson’s R&D
Fierce Biotech
Inflazome
Parkinson's Disease
R&D
Flag link:
Servier and Oncodesign announce Parkinson’s R&D tie-up
Servier and Oncodesign announce Parkinson’s R&D tie-up
Pharmaforum
Servier
Oncodesign
R&D
Parkinson's Disease
Flag link:
New insights emerge in an effort to repurpose Novartis’ cancer drug Tasigna in Parkinson’s disease
New insights emerge in an effort to repurpose Novartis’ cancer drug Tasigna in Parkinson’s disease
Fierce Biotech
Novartis
Tasigna
Parkinson's Disease
Flag link:
Axovant trumpets new clinical data after gene therapy pivot
Axovant trumpets new clinical data after gene therapy pivot
Fierce Biotech
Axovant
gene therapy
Parkinson's Disease
Tay Sachs
Flag link:
Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave
Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave
Xconomy
Acorda Therapeutics
Parkinson's Disease
Andrew Hindman
Inbrija
Flag link:
Voyager Shares Take Off on Parkinson's Disease Development Deal
Voyager Shares Take Off on Parkinson's Disease Development Deal
TheStreet.com
Voyager Therapeutics
gene therapy
AbbVie
Parkinson's Disease
Flag link:
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Cerevel Therapeutics
Pfizer
Otsuka
CMOs
Parkinson's Disease
epilepsy
Flag link:
Sunovion Receives Complete Response Letter from FDA for Parkinson’s Disease Drug
Sunovion Receives Complete Response Letter from FDA for Parkinson’s Disease Drug
CP Wire
Sunovion
Parkinson's Disease
apomorphine sublingual film
APL-130277
FDA
complete response letter
Flag link:
Sunovion Receives Complete Response Letter from FDA for Parkinson’s Disease Drug
Sunovion
Parkinson's Disease
apomorphine sublingual film
APL-130277
Flag link:
Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s
Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s
Xconomy
Voyager Therapeutics
Parkinson's Disease
Neurocrine
VY-AADC
gene therapy
Flag link:
FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up
FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up
BioSpace
FDA
Amneal
generics
Novartis
Exelon Patch
Alzheimer's disease
Parkinson's Disease
Flag link:
IBM’s AI-aided fingernail sensor could help with cardio, Parkinson’s treatment
IBM’s AI-aided fingernail sensor could help with cardio, Parkinson’s treatment
Mass Device
IBM
devices
fingernail sensors
Parkinson's Disease
cardiovascular disease
artificial intelligence
Flag link:
Belgian team to build patient-derived chips to model neuronal circuits in Parkinson's
Belgian team to build patient-derived chips to model neuronal circuits in Parkinson's
BioCentury
Parkinson's Disease
Flag link:
Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset
Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset
BioSpace
M&A
Coeptis Pharmaceuticals
Elto Pharma
Amarantus BioSciences
Parkinson's Disease
Flag link:
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App
CP WIre
UCB Pharma
Parkinson's Disease
artificial intelligence
mobile apps
Flag link:
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
Endpoints
targeted protein degradation
AbbVie
Mission Therapeutics
Alzheimer's disease
Parkinson's Disease
Flag link:
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App
UCB Pharma
Parkinson's Disease
AI
Flag link:

Pages